Digene Piloting DTC Ads In Effort To Capture HPV Test Market Share
This article was originally published in The Gray Sheet
Executive Summary
Digene expects to increase its 9% share of the U.S. human papillomavirus (HPV) testing market - estimated at 35 mil. tests annually - by 1%-1.5% per quarter during fiscal 2005